HCA Healthcare, Inc. $HCA Shares Purchased by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.1% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 67,138 shares of the company’s stock after buying an additional 100 shares during the period. KLP Kapitalforvaltning AS’s holdings in HCA Healthcare were worth $25,721,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare in the 1st quarter worth approximately $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare in the second quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in shares of HCA Healthcare in the second quarter worth approximately $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Robert W. Baird lifted their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research report on Thursday, August 14th. Barclays lifted their target price on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Finally, Wells Fargo & Company raised their price target on shares of HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $410.83.

HCA Healthcare Stock Up 0.9%

NYSE HCA opened at $437.46 on Wednesday. The stock has a market capitalization of $102.36 billion, a PE ratio of 18.39, a price-to-earnings-growth ratio of 1.36 and a beta of 1.40. The company has a 50 day moving average price of $401.26 and a two-hundred day moving average price of $374.10. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. During the same period in the previous year, the company earned $5.50 earnings per share. The company’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.